Published in N Engl J Med on October 22, 2014
The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United States. Clin Infect Dis (2015) 3.83
Ebola virus disease. BMJ (2014) 2.63
Ethical and practical considerations in providing critical care to patients with Ebola virus disease. Chest (2015) 2.05
Safety and feasibility of a strategy of early central venous catheter insertion in a deployed UK military Ebola virus disease treatment unit. Intensive Care Med (2015) 2.05
Transmission of Ebola viruses: what we know and what we do not know. MBio (2015) 1.90
Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014. Viruses (2014) 1.73
Human Ebola virus infection results in substantial immune activation. Proc Natl Acad Sci U S A (2015) 1.49
Characteristics and Clinical Management of a Cluster of 3 Patients With Ebola Virus Disease, Including the First Domestically Acquired Cases in the United States. Ann Intern Med (2015) 1.47
Systematic review of the literature on viral persistence and sexual transmission from recovered Ebola survivors: evidence and recommendations. BMJ Open (2016) 1.35
Ebola Virus Stability on Surfaces and in Fluids in Simulated Outbreak Environments. Emerg Infect Dis (2015) 1.29
Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs. Emerg Microbes Infect (2014) 1.18
Personal Protective Equipment: Protecting Health Care Providers in an Ebola Outbreak. Clin Ther (2015) 1.16
Clinical Management of Ebola Virus Disease in the United States and Europe. N Engl J Med (2016) 1.15
Severe Ebola virus infection complicated by gram-negative septicemia. N Engl J Med (2015) 1.09
Gastrointestinal and Hepatic Manifestations of Ebola Virus Infection. Dig Dis Sci (2015) 1.06
Risk factors for transmission of Ebola or Marburg virus disease: a systematic review and meta-analysis. Int J Epidemiol (2015) 1.05
Blood kinetics of Ebola virus in survivors and nonsurvivors. J Clin Invest (2015) 1.04
Persistence of Ebola virus in various body fluids during convalescence: evidence and implications for disease transmission and control. Epidemiol Infect (2016) 1.02
Ebola vaccine development plan: ethics, concerns and proposed measures. BMC Med Ethics (2016) 0.98
Treating the Host Response to Ebola Virus Disease with Generic Statins and Angiotensin Receptor Blockers. MBio (2015) 0.97
Relationship Between Ebola Virus Real-Time Quantitative Polymerase Chain Reaction-Based Threshold Cycle Value and Virus Isolation From Human Plasma. J Infect Dis (2015) 0.95
Out of Africa--caring for patients with Ebola. N Engl J Med (2014) 0.92
Unique human immune signature of Ebola virus disease in Guinea. Nature (2016) 0.92
Ebola virus disease and Marburg disease in pregnancy: a review and management considerations for filovirus infection. Obstet Gynecol (2015) 0.89
Presence and Persistence of Ebola or Marburg Virus in Patients and Survivors: A Rapid Systematic Review. PLoS Negl Trop Dis (2016) 0.88
Ebola virus disease complicated with viral interstitial pneumonia: a case report. BMC Infect Dis (2015) 0.88
Critical Care for Multiple Organ Failure Secondary to Ebola Virus Disease in the United States. Crit Care Med (2015) 0.88
High survival rates and associated factors among ebola virus disease patients hospitalized at donka national hospital, conakry, Guinea. J Vasc Interv Neurol (2015) 0.87
Ebolavirus and Haemorrhagic Syndrome. Sultan Qaboos Univ Med J (2015) 0.87
Time From Infection to Disease and Infectiousness for Ebola Virus Disease, a Systematic Review. Clin Infect Dis (2015) 0.86
Evaluation of RealStar Reverse Transcription-Polymerase Chain Reaction Kits for Filovirus Detection in the Laboratory and Field. J Infect Dis (2016) 0.84
Longitudinal characterization of dysfunctional T cell-activation during human acute Ebola infection. Cell Death Dis (2016) 0.84
Ebola Virus Infection: Overview and Update on Prevention and Treatment. Infect Dis Ther (2015) 0.83
Ebola virus disease and critical illness. Crit Care (2016) 0.82
Diagnosis of Ebola Virus Disease: Past, Present, and Future. Clin Microbiol Rev (2016) 0.82
Neurological Complications of Ebola Virus Infection. Neurotherapeutics (2016) 0.81
The multifunctional Ebola virus VP40 matrix protein is a promising therapeutic target. Future Virol (2015) 0.81
Ebola virus disease: What clinicians in the United States need to know. Am J Infect Control (2015) 0.81
The Ebola epidemic is ongoing in West Africa and responses from China are positive. Mil Med Res (2015) 0.81
Ebola Virus RNA Stability in Human Blood and Urine in West Africa's Environmental Conditions. Emerg Infect Dis (2016) 0.81
Ebola Virus Disease in Children, Sierra Leone, 2014-2015. Emerg Infect Dis (2016) 0.81
Ebola and psychological stress of health care professionals. Emerg Infect Dis (2015) 0.80
Recommendations for dealing with waste contaminated with Ebola virus: a Hazard Analysis of Critical Control Points approach. Bull World Health Organ (2016) 0.80
Development of an antibody capture ELISA using inactivated Ebola Zaire Makona virus. Med Microbiol Immunol (2015) 0.79
Partitioning of Viruses in Wastewater Systems and Potential for Aerosolization. Environ Sci Technol Lett (2016) 0.78
Ebola response in Sierra Leone: The impact on children. J Infect (2016) 0.78
Robust and sustained immune activation in human Ebola virus infection. Proc Natl Acad Sci U S A (2015) 0.78
Management of Microbiological Samples in a Confirmed Case of Ebola Virus Disease: Constraints and Limitations. J Clin Microbiol (2015) 0.77
Severe Ebola virus infection complicated by gram-negative septicemia. N Engl J Med (2015) 0.77
Addressing the Complications of Ebola and Other Viral Hemorrhagic Fever Infections: Using Insights from Bacterial and Fungal Sepsis. PLoS Pathog (2015) 0.76
Comparison of routes for achieving parenteral access with a focus on the management of patients with Ebola virus disease. Cochrane Database Syst Rev (2015) 0.76
Clinical features of suspected Ebola cases referred to the Moyamba ETC, Sierra Leone: challenges in the later stages of the 2014 outbreak. BMC Infect Dis (2016) 0.75
The Disinfection Characteristics of Ebola Virus Outbreak Variants. Sci Rep (2016) 0.75
Disinfection of Ebola Virus in Sterilized Municipal Wastewater. PLoS Negl Trop Dis (2017) 0.75
Ebola and cholera. Am J Trop Med Hyg (2015) 0.75
Critical care management of two patients with Ebola: a biocontainment unit demystified. Crit Care Med (2015) 0.75
Combined endothelial and epithelial barrier disruption of the colon may be a contributing factor to the Ebola sepsis-like syndrome. Patient Saf Surg (2015) 0.75
Understanding bleeding in ebola virus disease. Clin Adv Hematol Oncol (2015) 0.75
Clinical, virological, and biological parameters associated with outcomes of Ebola virus infection in Macenta, Guinea. JCI Insight (2017) 0.75
Clinical presentations and outcomes of patients with Ebola virus disease in Freetown, Sierra Leone. Infect Dis Poverty (2016) 0.75
Ebola virus disease and pregnancy: A review of the current knowledge of Ebola virus pathogenesis, maternal, and neonatal outcomes. Birth Defects Res (2017) 0.75
Treating the host response to emerging virus diseases: lessons learned from sepsis, pneumonia, influenza and Ebola. Ann Transl Med (2016) 0.75
Electrolyte and Metabolic Disturbances in Ebola Patients during a Clinical Trial, Guinea, 2015. Emerg Infect Dis (2016) 0.75
Caring for Critically Ill Ebola Virus Disease Patients With One Hand Tied Behind Your Back. Crit Care Med (2015) 0.75
Updates in diagnosis and management of Ebola hemorrhagic fever. J Res Med Sci (2016) 0.75
Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med (2003) 27.97
Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science (2003) 18.34
Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med (2014) 16.45
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science (2010) 9.61
Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature (2004) 9.53
Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. J Clin Microbiol (2002) 6.60
Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J Infect Dis (2008) 6.43
Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology (2008) 6.35
Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection. AIDS (2003) 5.28
Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection. J Exp Med (2004) 4.52
Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell (2009) 4.50
Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells. J Exp Med (2004) 4.37
Bats host major mammalian paramyxoviruses. Nat Commun (2012) 4.15
Infliximab as a rescue treatment in difficult-to-treat autoimmune hepatitis. J Hepatol (2012) 4.04
Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma. Liver Transpl (2006) 3.73
FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency. J Hepatol (2012) 3.57
Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation. J Virol (2002) 3.38
Virtual autopsy as an alternative to traditional medical autopsy in the intensive care unit: a prospective cohort study. Ann Intern Med (2012) 3.29
Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes. Nat Immunol (2005) 3.23
Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein. J Immunol (2005) 2.84
Faldaprevir and deleobuvir for HCV genotype 1 infection. N Engl J Med (2013) 2.68
Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis. J Exp Med (2006) 2.54
Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequences. J Virol (2003) 2.53
Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells. J Virol (2009) 2.51
Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. Blood (2005) 2.50
The neurological syndrome in adults during the 2011 northern German E. coli serotype O104:H4 outbreak. Brain (2012) 2.49
Functional analysis of hepatitis B virus reactivating in hepatitis B surface antigen-negative individuals. Hepatology (2005) 2.49
Binding of hepatitis B virus to its cellular receptor alters the expression profile of genes of bile acid metabolism. Hepatology (2014) 2.39
HIV-1 specific CD8+ T cells with an effector phenotype and control of viral replication. Lancet (2004) 2.36
A Variegated Squirrel Bornavirus Associated with Fatal Human Encephalitis. N Engl J Med (2015) 2.34
Chikungunya fever in travelers returning to Europe from the Indian Ocean region, 2006. Emerg Infect Dis (2008) 2.29
Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections. J Virol (2010) 2.28
Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles. J Biol Chem (2003) 2.26
Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides. J Virol (2004) 2.21
Death after percutaneous dilatational tracheostomy: a systematic review and analysis of risk factors. Crit Care (2013) 2.17
Limited durability of viral control following treated acute HIV infection. PLoS Med (2004) 2.16
Consistent patterns in the development and immunodominance of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T-cell responses following acute HIV-1 infection. J Virol (2002) 2.14
RT-PCR assay for detection of Lassa virus and related Old World arenaviruses targeting the L gene. Trans R Soc Trop Med Hyg (2007) 2.10
Response to imported case of Marburg hemorrhagic fever, the Netherland. Emerg Infect Dis (2009) 2.07
Dual role of collagen in factor XII-dependent thrombus formation. Blood (2009) 2.01
Radial Artery Applanation Tonometry for Continuous Noninvasive Cardiac Output Measurement: A Comparison With Intermittent Pulmonary Artery Thermodilution in Patients After Cardiothoracic Surgery. Crit Care Med (2015) 2.00
Primary biliary "cirrhosis": time to replace a misnomer. Hepatology (2014) 1.98
Effectiveness and safety of minilaparoscopy-guided spleen biopsy: a retrospective series of 57 cases. Surg Endosc (2012) 1.96
Long-term survival of an urban fruit bat seropositive for Ebola and Lagos bat viruses. PLoS One (2010) 1.95
Mastomys natalensis and Lassa fever, West Africa. Emerg Infect Dis (2006) 1.94
Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes. J Virol (2008) 1.94
Imported Lassa fever in Germany: surveillance and management of contact persons. Clin Infect Dis (2003) 1.91
Blockade of bradykinin receptor B1 but not bradykinin receptor B2 provides protection from cerebral infarction and brain edema. Stroke (2008) 1.90
HIV-1 Nef is preferentially recognized by CD8 T cells in primary HIV-1 infection despite a relatively high degree of genetic diversity. AIDS (2004) 1.89
Concurrent autoimmune diseases in patients with autoimmune hepatitis. J Clin Gastroenterol (2010) 1.86
Outbreaks of disease suspected of being due to human monkeypox virus infection in the Democratic Republic of Congo in 2001. J Clin Microbiol (2002) 1.86
A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo. Blood (2010) 1.83
Molecular diagnostics of viral hemorrhagic fevers. Antiviral Res (2003) 1.82
Factor XII inhibition reduces thrombus formation in a primate thrombosis model. Blood (2014) 1.81
Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. J Hepatol (2010) 1.80
Augmentation of HIV-1-specific T helper cell responses in chronic HIV-1 infection by therapeutic immunization. AIDS (2003) 1.80
Immune tolerance: what is unique about the liver. J Autoimmun (2009) 1.79
HIV-1-specific cytotoxicity is preferentially mediated by a subset of CD8(+) T cells producing both interferon-gamma and tumor necrosis factor-alpha. Blood (2004) 1.78
Inhibition of filovirus replication by the zinc finger antiviral protein. J Virol (2006) 1.76
Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol (2006) 1.76
The calcium sensor STIM1 is an essential mediator of arterial thrombosis and ischemic brain infarction. J Exp Med (2008) 1.74
Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses. J Immunol Methods (2003) 1.73
Monitoring of clinical and laboratory data in two cases of imported Lassa fever. Microbes Infect (2002) 1.71
Replicon system for Lassa virus. J Virol (2004) 1.69
Virion half-life in chronic hepatitis B infection is strongly correlated with levels of viremia. Hepatology (2008) 1.68
Prediction of short-term and long-term outcomes after cardiac arrest: a prospective multivariate approach combining biochemical, clinical, electrophysiological, and neuropsychological investigations. Crit Care Med (2007) 1.67
Crimean-Congo hemorrhagic fever in Kosovo. J Clin Microbiol (2002) 1.64
GB virus C (GBV-C) infection in hepatitis C virus (HCV)/HIV-coinfected patients receiving HCV treatment: importance of the GBV-C genotype. J Infect Dis (2006) 1.64
Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany. J Infect Dis (2011) 1.62
Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease. J Virol (2010) 1.61
Combination of intermittent haemodialysis and high-volume continuous haemofiltration for the treatment of severe metformin-induced lactic acidosis. Nephrol Dial Transplant (2004) 1.61
The indications for liver biopsy. Dtsch Arztebl Int (2012) 1.60
Evaluation of F-actin ELISA for the diagnosis of autoimmune hepatitis. Am J Gastroenterol (2006) 1.59
The N-terminal domain of the arenavirus L protein is an RNA endonuclease essential in mRNA transcription. PLoS Pathog (2010) 1.57
Do centrally pre-prepared solutions achieve more reliable drug concentrations than solutions prepared on the ward? Intensive Care Med (2011) 1.57
Pancreas and liver injury are associated in individuals with increased alcohol consumption. Clin Gastroenterol Hepatol (2009) 1.56
Epizootic emergence of Usutu virus in wild and captive birds in Germany. PLoS One (2012) 1.55
Pregnancy in primary sclerosing cholangitis. Gut (2011) 1.55
Isolation and phylogenetic analysis of Sindbis viruses from mosquitoes in Germany. J Clin Microbiol (2010) 1.55
Isolation of usutu virus in Germany. Am J Trop Med Hyg (2011) 1.55
Ross River virus infection in a traveller returning from northern Australia. Med Microbiol Immunol (2009) 1.54
Evidence for novel hepaciviruses in rodents. PLoS Pathog (2013) 1.54
The magnitude and breadth of hepatitis C virus-specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1. Blood (2004) 1.53
Virus detection and monitoring of viral load in Crimean-Congo hemorrhagic fever virus patients. Emerg Infect Dis (2007) 1.53
Beyond help: direct effector functions of human immunodeficiency virus type 1-specific CD4(+) T cells. J Virol (2004) 1.51
Sequence analysis of L RNA of Lassa virus. Virology (2004) 1.50
Bat3 promotes T cell responses and autoimmunity by repressing Tim-3–mediated cell death and exhaustion. Nat Med (2012) 1.48
Intrinsic pathway of coagulation and arterial thrombosis. Arterioscler Thromb Vasc Biol (2007) 1.47
Functional analysis of complex hepatitis B virus variants associated with development of liver cirrhosis. Gastroenterology (2006) 1.46